There are currently supply issues with pioglitazone tablets (all strengths).
Deliveries are expected during December and January, however overall supply may be limited. In order to conserve supplies to ensure that patient management is not compromised it is recommended that prescription duration is limited to the amount the patient requires.
UKMi have produced detailed guidance for prescribers which outlines management options and alternative agents to pioglitazone. Click here to view the guidance from UKMi.